What We Don't Do

Boyar Research takes a private equity approach to analyzing companies we profile. For us to profile common shares of a company for our clients, that enterprise must be intrinsically undervalued and have a sustainable business model. Simply put, we will not feature companies that we feel are “fads.”

We also avoid profiling companies heavily reliant on technology that can quickly become obsolete. In addition, we do not feature biotechnology companies, as it takes specialized expertise to correctly analyze those firms. Moreover, biotech companies often have binary outcomes in terms of investment success, which does not fit our margin-of-safety approach to investing.